Thomas Gervais is a seasoned professional in the biopharmaceutical manufacturing sector, currently serving as Vice President of Manufacturing at MacroGenics, Inc. since September 2023. Gervais previously held the position of Vice President, Process Development and Manufacturing at NexImmune, Inc., and has extensive experience at Samsung Biologics, where roles included Head of MSAT Business Unit and Senior Director for MSAT (DS1/DS2). During tenure at Samsung, Gervais led substantial transformations and expansions within the MSAT organization, managing large teams, significant budgets, and numerous technology transfer and manufacturing projects. Previous experience also includes key roles at Bristol-Myers Squibb and Centocor, contributing to advancements in manufacturing sciences and technologies. Gervais holds a Bachelor of Science in Chemical Engineering from Penn State University and a Ph.D. in Chemical Engineering from the University of Virginia.
This person is not in any teams
This person is not in any offices